Charles L. Shapiro

Identifying survival associated morphological features of triple negative breast cancer using multiple datasets

Chao Wang, Raghu Machiraju, Thierry Pécot, 2013, Journal of the American Medical Informatics Association : JAMIA.

Mapping Geographic Zones of Cancer Risk with Epigenetic Biomarkers in Normal Breast Tissue

Timothy J. Yeatman, Charis Eng, Charles L. Shapiro, 2006, Clinical Cancer Research.

DNA Damage and Cellular Stress Responses KIAA 0101 Interacts with BRCA 1 and Regulates Centrosome Number

Jeffrey D. Parvin, Kun Huang, Gang He, 2011 .

Sympathetic and parasympathetic activity in cancer-related fatigue: More evidence for a physiological substrate in cancer survivors

Julian F. Thayer, John J. Sollers, Beom Seuk Hwang, 2011, Psychoneuroendocrinology.

Androgen Receptor Status Is a Prognostic Marker in Non-Basal Triple Negative Breast Cancers and Determines Novel Therapeutic Options

Carolyn Paisie, Serdar Balci, Carlo M. Croce, 2014, PloS one.

In vivo NCL targeting affects breast cancer aggressiveness through miRNA regulation

Michael A. Freitas, Guido Marcucci, Stefano Volinia, 2013, The Journal of experimental medicine.

Overcoming Trastuzumab Resistance in HER2-Overexpressing Breast Cancer Cells by Using a Novel Celecoxib-Derived Phosphoinositide-Dependent Kinase-1 Inhibitor

Ching-Yu Chen, Charles L. Shapiro, C. Shapiro, 2006, Molecular Pharmacology.